Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells
Abstract Background Resistance to platinum-based chemotherapy is one of the crucial problems in ovarian cancer treatment. Ghrelin, a widely distributed peptide hormone, participates in a series of cancer progression. The aim of this study is to determine whether ghrelin influences the sensitivity of...
Guardado en:
Autores principales: | Yun Leng, Can Zhao, Guoliang Yan, Shuangyue Xu, Yinggui Yang, Ting Gong, Xin Li, Chenglin Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c17689f14f34f60b7bf4f4733970817 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
por: Mitchell Clark, et al.
Publicado: (2021) -
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A
por: Jin Wang, et al.
Publicado: (2021) -
State of the problem of early diagnosis and treatment of benign ovarian tumors in postmenopausal patients (literature review)
por: Nataliia M. Podzolkova, et al.
Publicado: (2021) -
The concomitant estrogen-dependent diseases and the ovarian reserve condition for patients with severe peritoneal endometriosis, included in the vitro fertilization programmes
por: Irina Yu. Ershova, et al.
Publicado: (2021) -
A ten-year retrospective review of maternal cardiac arrest: Incidence, characteristics, causes, and outcomes in a tertiary-care hospital in a developing country
por: Patchareya Nivatpumin, et al.
Publicado: (2021)